Citadel Advisors
GDNRW

Citadel Advisors’s Gardiner Healthcare Acquisitions Corp. Warrant GDNRW Stock Holding History

Citadel Advisors’s Portfolio GDNRW Stock Details GDNRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-53,192
Closed -$3.19K – 15575
2023
Q3 		$3.19K Buy
53,192
+1,686
+3% +$92 ﹤0.01% 13620
2023
Q2 		$3.6K Buy
51,506
+6,890
+15% +$605 ﹤0.01% 13677
2023
Q1 		$4.27K Sell
44,616
-2,946
-6% -$269 ﹤0.01% 13971
2022
Q4 		$6.26K Buy
+47,562
New +$4.43K ﹤0.01% 13931

Citadel Advisors's GDNRW Position: Q4 2023 in Review

Citadel Advisors sold out of Gardiner Healthcare Acquisitions Corp. Warrant (GDNRW) in Q4 2023, closing a stake of 53,192 shares — an estimated $3.19K sold.

Citadel Advisors first reported a position in GDNRW in Q4 2022 and held it in 4 quarters. The position peaked at $6.26K in Q4 2022. 0 funds tracked by Wall St. Rank hold GDNRW as of Q4 2023.

  • Citadel Advisors reported no remaining Gardiner Healthcare Acquisitions Corp. Warrant position as of Q4 2023 after selling out during the quarter.
  • Citadel Advisors sold 53,192 Gardiner Healthcare Acquisitions Corp. Warrant shares in Q4 2023, an estimated $3.19K.
  • Citadel Advisors first reported a position in Gardiner Healthcare Acquisitions Corp. Warrant in Q4 2022 and held it in 4 quarters.
  • Citadel Advisors's Gardiner Healthcare Acquisitions Corp. Warrant position peaked at $6.26K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Gardiner Healthcare Acquisitions Corp. Warrant as of Q4 2023.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.